Viewing Study NCT00481312

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:44 PM
Ignite Modification Date: 2026-01-02 @ 11:57 AM
Study NCT ID: NCT00481312
Status: COMPLETED
Last Update Posted: 2012-05-07
First Post: 2007-05-31
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Dexmedetomidine Versus Midazolam for Continuous Sedation in the Intensive Care Unit (ICU)
Sponsor: Orion Corporation, Orion Pharma
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Continuous Sedation in Initially Sedated Adults in ICU View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Initial Sedation View
None Mechanical ventilation View